Expression, regulation and function of microRNAs in multiple sclerosis.

Expression, regulation and function of microRNAs in multiple sclerosis.
复制标题

多发性硬化症中 microRNA 的表达、调控和功能。

DOI:
10.7150/ijms.8647
复制
发表时间:
2014
影响因子:
3.6
通讯作者:
Nagarkatti P
Nagarkatti P
中科院分区:
医学4区
文献类型:
--
作者:
Ma X;Zhou J;Zhong Y;Jiang L;Mu P;Li Y;Singh N;Nagarkatti M;Nagarkatti P

文献摘要

参考文献

被引文献

相似文献

MicroRNAs(MiRNAs)是19-25个核苷酸的单链RNAs,在转录后基因沉默中起着重要作用。已有研究表明,多发性硬化症(MS)患者的miRNAs表达异常。例如,miR-21、miR-142-3p、miR-146a、miR-146b、miR-155和miR-326在MS患者和小鼠模型的外周血单个核细胞(PBMC)和脑白质病变中表达上调。这些上调的miRNAs可作为MS的标志,并在MS的发病机制中发挥关键作用。此外,miR-15a、miR-19a、miR-22、miR-210和miR-223在调节性T细胞(Tregs)以及MS患者的血浆、血细胞、PBMC和脑白质组织中均上调,提示这些上调的miRNAs和Tregs可能在MS的发病机制中起作用。相反,其他miRNAs如miR-15a、miR-15b、miR-181c和miR-328在MS患者中表达下调,治疗MS的药物如干扰素-β和格列替拉默可能调节miRNA的表达,从而对MS患者有好处。MiR-155、miR-326等表达异常的miRNAs可作为MS的诊断标志物和治疗靶点。
MicroRNAs (miRNAs) are single-stranded 19-25 nucleotide-long RNAs and have an important role in post-transcriptional gene silencing. It has been demonstrated that miRNAs are dysregulated in patients with multiple sclerosis (MS). For instance, miR-21, miR-142-3p, miR-146a, miR-146b, miR-155 and miR-326 were up-regulated in both peripheral blood mononuclear cells (PBMCs) and brain white matter lesions from MS patients and mouse model as well. These up-regulated miRNAs may be used as a signature for MS and play critical roles in MS pathogenesis. Moreover, miR-15a, miR-19a, miR-22, miR-210 and miR-223 were up-regulated in both regulatory T cells (Tregs) and other samples such as plasma, blood cells, PBMCs and brain white matter tissues from MS patients, suggesting that these up-regulated miRNAs and Tregs may also play a role in MS pathogenesis. Contrarily, other miRNAs such as miR-15a, miR-15b, miR-181c and miR-328 were down-regulated in MS. Drugs such as interferon-β and glatiramer acetate for MS treatment may regulate miRNA expression and thus have benefits for MS patients. The dysregulated miRNAs such as miR-155 and miR-326 may be used as diagnostic markers and therapeutic targets for MS.
DOI: 10.1038/ni.1798
发表时间: 2009-12-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Du, Changsheng;Liu, Chang;Pei, Gang
通讯作者: Pei, Gang
多发性硬化症患者外周血中的干扰素β治疗过程中的microRNA表达变化。
DOI: 10.3390/ijms140816087
发表时间: 2013-08-05
影响因子: 5.6
作者:
Hecker M;Thamilarasan M;Koczan D;Schröder I;Flechtner K;Freiesleben S;Füllen G;Thiesen HJ;Zettl UK
通讯作者: Zettl UK
DOI: 10.1016/j.jneuroim.2010.06.009
发表时间: 2010-09-14
影响因子: 3.3
作者:
De Santis, Giuseppe;Ferracin, Manuela;Granieri, Enrico
通讯作者: Granieri, Enrico
DOI: 10.1177/1352458513496343
发表时间: 2014-03-01
影响因子: 5.8
作者:
Keller, Andreas;Leidinger, Petra;Ruprecht, Klemens
通讯作者: Ruprecht, Klemens
DOI: 10.3109/00207454.2012.678444
发表时间: 2012-08-01
影响因子: 2.2
作者:
Cetrulo Lorenzi, Julio Cesar;Brum, Doralina G.;Silva, Wilson Araujo, Jr.
通讯作者: Silva, Wilson Araujo, Jr.